Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-01
1997-07-08
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514397, 5142282, 5142328, 5142325, 514253, 514365, 514374, 514434, 514435, 514452, 514453, 5142285, 544150, 544378, 546197, 548146, 548215, 5483415, 548526, 548525, 549 15, 549 18, 549358, 549387, A61K 3141, A61K 3136, C07D23920, C07D31908
Patent
active
056461755
ABSTRACT:
Novel carbamoyloxylabdanes, intermediates and processes for the preparation thereof, and methods for reducing intraocular pressure and treating cardiac failure utilizing compounds and compositions thereof are disclosed.
REFERENCES:
patent: 3631039 (1971-12-01), Andrews
patent: 4088659 (1978-05-01), Bhat et al.
patent: 4118508 (1978-10-01), Bhat et al.
patent: 4134986 (1979-01-01), Bajwa et al.
patent: 4476140 (1984-10-01), Sears
patent: 4517200 (1985-05-01), Kreutner et al.
patent: 4564626 (1986-01-01), Kreutner
patent: 4639443 (1987-01-01), Kosley
patent: 4639446 (1987-01-01), Kosley
patent: 4920146 (1990-04-01), Kosley, Jr. et al.
patent: 5093336 (1992-03-01), Kosley, Jr. et al.
patent: 5374650 (1994-12-01), Kosley, Jr. et al.
A. Laurenza, et al., Molecular Pharmacology, 32, 133 (1987).
Calbiochem.RTM. Biochemical/Immunochemical Catalog, 1988 New Product Supplement, p.18.
Biologics, 13 (No.4), Oct. 1987.
Calbiochem.RTM. Biochemical/Immunochemical Catalog 1987, p. 102.
S. P. Bartels, et al., Current Eye Research, 2, 673 (Feb. 1983).
R. J. Cherill, et al., Abstracts of Paper, 192nd ACS National Meeting, Medi, No. 48 (Sep. 1986).
J. Caprioli and M. Sears, The Yale Journal of Biology and Medicine, 57, 283 (1984).
K.B. Seamon and J.W. Daly, Trends in Pharmacological Sciences, 48, 120 (1983).
K.B. Seamon and J.W. Daly, J.Cyclic Nucleotide Research, 7, 201 (1981).
J. Caprioli, et al. Abstracts, Association for Research in Vision and Opthalmology, 233 (1986-5:15).
S.P. Bartels, et al., Current Eye Research, 6, 307 (187).
K. B. Seamon and J. W. Daly in "Advances in Cyclic Nucleotide and Proetin Phosphorylation Research", vol. 20, P. Greengard & G. A. Robison, Editors, Raven Press, New York, NY,1986, pp. 1 to 150.
N.J. de Souza, et al., Medicinal Research Reviews, 3, 201 (1983).
S.V. Bhat, et al., J. Med. Chem., 26, 486 (1983).
K. B. Seamon, et al., J. Med. Chem., 26, 436 (1983).
S.V. Bhat, et al., Tetrahedron Letters, 1669 (1977).
S.V. Bhat, et al., J.C.S. Perkin I, 767 (1982).
J. Caprioly, et al., Investigative Ophthalmology and Visual Science, 25, 268 (1984).
J. Caprioli snd M. Sears, The Lancet, 958 (1983).
K. B. Seamon, et al., Proc. Natl. Acad. Sci. USA, 78, 3363 (1981).
K. Seamon and J. W. Daly, The Journal of Biological Chemistry, 256, 9799 (1981).
J. Takeda, et al., The Journal of Investigative Dermatology, 81, 236 (1983).
J. Takeda, et al., The Journal of Investigative Dermatology, 81, 131 (1983).
H. Hzuka, et al., Biochimica et Biophysica Acta., 444, 685 (1979).
H. Hzuka, et al., Biochimica et Biophysica Acta., 437, 150(1976).
J.J. Voorhees, The Journal of Investigative Dermatology, 59, 114 (1972).
K. M. Halprin, et al., The Journal of Investigative Dermatology, 65, 170 (1975).
W. P. Raab, International Journal of Clinical Pharmacology, Therapy and Toxicology, 18, 212 (1980).
Cherill Robert Joseph
Kosley, Jr. Raymond W.
O'Malley Gerard
Davis Zinna Northington
Hoechst Marion Roussel Inc.
Wittekind R. R.
LandOfFree
Carbamoyloxylabdane compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamoyloxylabdane compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamoyloxylabdane compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2409140